# Boehringer Ingelheim Espana S.A. – FDA Inspection, Jun 30, 2023

Source: https://www.keypedia.com/records/fda_inspections/boehringer-ingelheim-espana-sa/79f049e5-6912-47e0-a897-c910cc1cd3a9
Source feed: FDA_Inspections

> FDA inspection 1238045 of Boehringer Ingelheim Espana S.A., June 30, 2023. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1238045
- Company Name: Boehringer Ingelheim Espana S.A.
- Inspection Date: 2023-06-30
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

Company: https://www.keypedia.com/companies/boehringer-ingelheim-espana-sa/afd6c8fe-92cc-4db4-8157-94020bcf06d6

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c